List of Tables
Table 1. Global Dipeptidyl Peptidase-4 Inhibitors Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Dipeptidyl Peptidase-4 Inhibitors Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Dipeptidyl Peptidase-4 Inhibitors Market Competitive Situation by Manufacturers in 2024
Table 4. Global Dipeptidyl Peptidase-4 Inhibitors Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Dipeptidyl Peptidase-4 Inhibitors Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Dipeptidyl Peptidase-4 Inhibitors Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Dipeptidyl Peptidase-4 Inhibitors Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Dipeptidyl Peptidase-4 Inhibitors Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Dipeptidyl Peptidase-4 Inhibitors, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Dipeptidyl Peptidase-4 Inhibitors, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Dipeptidyl Peptidase-4 Inhibitors, Product Type & Application
Table 12. Global Key Manufacturers of Dipeptidyl Peptidase-4 Inhibitors, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Dipeptidyl Peptidase-4 Inhibitors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dipeptidyl Peptidase-4 Inhibitors as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Dipeptidyl Peptidase-4 Inhibitors Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Dipeptidyl Peptidase-4 Inhibitors Sales by Region (2020-2025) & (K Units)
Table 18. Global Dipeptidyl Peptidase-4 Inhibitors Sales Market Share by Region (2020-2025)
Table 19. Global Dipeptidyl Peptidase-4 Inhibitors Sales by Region (2026-2031) & (K Units)
Table 20. Global Dipeptidyl Peptidase-4 Inhibitors Sales Market Share by Region (2026-2031)
Table 21. Global Dipeptidyl Peptidase-4 Inhibitors Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Dipeptidyl Peptidase-4 Inhibitors Revenue Market Share by Region (2020-2025)
Table 23. Global Dipeptidyl Peptidase-4 Inhibitors Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Dipeptidyl Peptidase-4 Inhibitors Revenue Market Share by Region (2026-2031)
Table 25. North America Dipeptidyl Peptidase-4 Inhibitors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Dipeptidyl Peptidase-4 Inhibitors Sales by Country (2020-2025) & (K Units)
Table 27. North America Dipeptidyl Peptidase-4 Inhibitors Sales by Country (2026-2031) & (K Units)
Table 28. North America Dipeptidyl Peptidase-4 Inhibitors Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Dipeptidyl Peptidase-4 Inhibitors Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Dipeptidyl Peptidase-4 Inhibitors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Dipeptidyl Peptidase-4 Inhibitors Sales by Country (2020-2025) & (K Units)
Table 32. Europe Dipeptidyl Peptidase-4 Inhibitors Sales by Country (2026-2031) & (K Units)
Table 33. Europe Dipeptidyl Peptidase-4 Inhibitors Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Dipeptidyl Peptidase-4 Inhibitors Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Dipeptidyl Peptidase-4 Inhibitors Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Dipeptidyl Peptidase-4 Inhibitors Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Dipeptidyl Peptidase-4 Inhibitors Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Dipeptidyl Peptidase-4 Inhibitors Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Dipeptidyl Peptidase-4 Inhibitors Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Dipeptidyl Peptidase-4 Inhibitors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Dipeptidyl Peptidase-4 Inhibitors Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Dipeptidyl Peptidase-4 Inhibitors Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Dipeptidyl Peptidase-4 Inhibitors Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Dipeptidyl Peptidase-4 Inhibitors Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Dipeptidyl Peptidase-4 Inhibitors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Dipeptidyl Peptidase-4 Inhibitors Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Dipeptidyl Peptidase-4 Inhibitors Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Dipeptidyl Peptidase-4 Inhibitors Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Dipeptidyl Peptidase-4 Inhibitors Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Dipeptidyl Peptidase-4 Inhibitors Sales (K Units) by Type (2020-2025)
Table 51. Global Dipeptidyl Peptidase-4 Inhibitors Sales (K Units) by Type (2026-2031)
Table 52. Global Dipeptidyl Peptidase-4 Inhibitors Sales Market Share by Type (2020-2025)
Table 53. Global Dipeptidyl Peptidase-4 Inhibitors Sales Market Share by Type (2026-2031)
Table 54. Global Dipeptidyl Peptidase-4 Inhibitors Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Dipeptidyl Peptidase-4 Inhibitors Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Dipeptidyl Peptidase-4 Inhibitors Revenue Market Share by Type (2020-2025)
Table 57. Global Dipeptidyl Peptidase-4 Inhibitors Revenue Market Share by Type (2026-2031)
Table 58. Global Dipeptidyl Peptidase-4 Inhibitors Price (US$/Unit) by Type (2020-2025)
Table 59. Global Dipeptidyl Peptidase-4 Inhibitors Price (US$/Unit) by Type (2026-2031)
Table 60. Global Dipeptidyl Peptidase-4 Inhibitors Sales (K Units) by Application (2020-2025)
Table 61. Global Dipeptidyl Peptidase-4 Inhibitors Sales (K Units) by Application (2026-2031)
Table 62. Global Dipeptidyl Peptidase-4 Inhibitors Sales Market Share by Application (2020-2025)
Table 63. Global Dipeptidyl Peptidase-4 Inhibitors Sales Market Share by Application (2026-2031)
Table 64. Global Dipeptidyl Peptidase-4 Inhibitors Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Dipeptidyl Peptidase-4 Inhibitors Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Dipeptidyl Peptidase-4 Inhibitors Revenue Market Share by Application (2020-2025)
Table 67. Global Dipeptidyl Peptidase-4 Inhibitors Revenue Market Share by Application (2026-2031)
Table 68. Global Dipeptidyl Peptidase-4 Inhibitors Price (US$/Unit) by Application (2020-2025)
Table 69. Global Dipeptidyl Peptidase-4 Inhibitors Price (US$/Unit) by Application (2026-2031)
Table 70. Merck Company Information
Table 71. Merck Description and Business Overview
Table 72. Merck Dipeptidyl Peptidase-4 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Merck Dipeptidyl Peptidase-4 Inhibitors Product
Table 74. Merck Recent Developments/Updates
Table 75. Boehringer Ingelheim Company Information
Table 76. Boehringer Ingelheim Description and Business Overview
Table 77. Boehringer Ingelheim Dipeptidyl Peptidase-4 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Boehringer Ingelheim Dipeptidyl Peptidase-4 Inhibitors Product
Table 79. Boehringer Ingelheim Recent Developments/Updates
Table 80. AstraZeneca Company Information
Table 81. AstraZeneca Description and Business Overview
Table 82. AstraZeneca Dipeptidyl Peptidase-4 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. AstraZeneca Dipeptidyl Peptidase-4 Inhibitors Product
Table 84. AstraZeneca Recent Developments/Updates
Table 85. Takeda Pharmaceutical Company Information
Table 86. Takeda Pharmaceutical Description and Business Overview
Table 87. Takeda Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Takeda Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Product
Table 89. Takeda Pharmaceutical Recent Developments/Updates
Table 90. Novartis Company Information
Table 91. Novartis Description and Business Overview
Table 92. Novartis Dipeptidyl Peptidase-4 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Novartis Dipeptidyl Peptidase-4 Inhibitors Product
Table 94. Novartis Recent Developments/Updates
Table 95. Jiangsu Hansoh Pharmaceutical Company Information
Table 96. Jiangsu Hansoh Pharmaceutical Description and Business Overview
Table 97. Jiangsu Hansoh Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Jiangsu Hansoh Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Product
Table 99. Jiangsu Hansoh Pharmaceutical Recent Developments/Updates
Table 100. Qilu Pharmaceutical Company Information
Table 101. Qilu Pharmaceutical Description and Business Overview
Table 102. Qilu Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Qilu Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Product
Table 104. Qilu Pharmaceutical Recent Developments/Updates
Table 105. Beijing Tide Pharmaceutical Company Information
Table 106. Beijing Tide Pharmaceutical Description and Business Overview
Table 107. Beijing Tide Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Beijing Tide Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Product
Table 109. Beijing Tide Pharmaceutical Recent Developments/Updates
Table 110. CTTQ Company Information
Table 111. CTTQ Description and Business Overview
Table 112. CTTQ Dipeptidyl Peptidase-4 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. CTTQ Dipeptidyl Peptidase-4 Inhibitors Product
Table 114. CTTQ Recent Developments/Updates
Table 115. Jiangsu Deyuan Pharmaceutical Company Information
Table 116. Jiangsu Deyuan Pharmaceutical Description and Business Overview
Table 117. Jiangsu Deyuan Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Jiangsu Deyuan Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Product
Table 119. Jiangsu Deyuan Pharmaceutical Recent Developments/Updates
Table 120. Jiujiang Zhongtian Pharmaceutical Company Information
Table 121. Jiujiang Zhongtian Pharmaceutical Description and Business Overview
Table 122. Jiujiang Zhongtian Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Jiujiang Zhongtian Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Product
Table 124. Jiujiang Zhongtian Pharmaceutical Recent Developments/Updates
Table 125. Yabao Pharmaceutical Company Information
Table 126. Yabao Pharmaceutical Description and Business Overview
Table 127. Yabao Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Yabao Pharmaceutical Dipeptidyl Peptidase-4 Inhibitors Product
Table 129. Yabao Pharmaceutical Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Dipeptidyl Peptidase-4 Inhibitors Distributors List
Table 133. Dipeptidyl Peptidase-4 Inhibitors Customers List
Table 134. Dipeptidyl Peptidase-4 Inhibitors Market Trends
Table 135. Dipeptidyl Peptidase-4 Inhibitors Market Drivers
Table 136. Dipeptidyl Peptidase-4 Inhibitors Market Challenges
Table 137. Dipeptidyl Peptidase-4 Inhibitors Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
Table 141. Authors List of This Report
List of Figures
Figure 1. Product Picture of Dipeptidyl Peptidase-4 Inhibitors
Figure 2. Global Dipeptidyl Peptidase-4 Inhibitors Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Dipeptidyl Peptidase-4 Inhibitors Market Share by Type: 2024 & 2031
Figure 4. Sitagliptin Product Picture
Figure 5. Saxagliptin Product Picture
Figure 6. Vildagliptin Product Picture
Figure 7. Linagliptin Product Picture
Figure 8. Alogliptin Product Picture
Figure 9. Other Product Picture
Figure 10. Global Dipeptidyl Peptidase-4 Inhibitors Market Value by Application (2020-2031) & (US$ Million)
Figure 11. Global Dipeptidyl Peptidase-4 Inhibitors Market Share by Application: 2024 & 2031
Figure 12. Hospital
Figure 13. Clinic
Figure 14. Other
Figure 15. Global Dipeptidyl Peptidase-4 Inhibitors Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Dipeptidyl Peptidase-4 Inhibitors Market Size (2020-2031) & (US$ Million)
Figure 17. Global Dipeptidyl Peptidase-4 Inhibitors Sales (2020-2031) & (K Units)
Figure 18. Global Dipeptidyl Peptidase-4 Inhibitors Average Price (US$/Unit) & (2020-2031)
Figure 19. Dipeptidyl Peptidase-4 Inhibitors Report Years Considered
Figure 20. Dipeptidyl Peptidase-4 Inhibitors Sales Share by Manufacturers in 2024
Figure 21. Global Dipeptidyl Peptidase-4 Inhibitors Revenue Share by Manufacturers in 2024
Figure 22. Global 5 and 10 Largest Dipeptidyl Peptidase-4 Inhibitors Players: Market Share by Revenue in Dipeptidyl Peptidase-4 Inhibitors in 2024
Figure 23. Dipeptidyl Peptidase-4 Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 24. Global Dipeptidyl Peptidase-4 Inhibitors Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 25. North America Dipeptidyl Peptidase-4 Inhibitors Sales Market Share by Country (2020-2031)
Figure 26. North America Dipeptidyl Peptidase-4 Inhibitors Revenue Market Share by Country (2020-2031)
Figure 27. United States Dipeptidyl Peptidase-4 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Canada Dipeptidyl Peptidase-4 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Europe Dipeptidyl Peptidase-4 Inhibitors Sales Market Share by Country (2020-2031)
Figure 30. Europe Dipeptidyl Peptidase-4 Inhibitors Revenue Market Share by Country (2020-2031)
Figure 31. Germany Dipeptidyl Peptidase-4 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. France Dipeptidyl Peptidase-4 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. U.K. Dipeptidyl Peptidase-4 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Italy Dipeptidyl Peptidase-4 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Russia Dipeptidyl Peptidase-4 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Asia Pacific Dipeptidyl Peptidase-4 Inhibitors Sales Market Share by Region (2020-2031)
Figure 37. Asia Pacific Dipeptidyl Peptidase-4 Inhibitors Revenue Market Share by Region (2020-2031)
Figure 38. China Dipeptidyl Peptidase-4 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Japan Dipeptidyl Peptidase-4 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. South Korea Dipeptidyl Peptidase-4 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. India Dipeptidyl Peptidase-4 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Australia Dipeptidyl Peptidase-4 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. China Taiwan Dipeptidyl Peptidase-4 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Southeast Asia Dipeptidyl Peptidase-4 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Latin America Dipeptidyl Peptidase-4 Inhibitors Sales Market Share by Country (2020-2031)
Figure 46. Latin America Dipeptidyl Peptidase-4 Inhibitors Revenue Market Share by Country (2020-2031)
Figure 47. Mexico Dipeptidyl Peptidase-4 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Brazil Dipeptidyl Peptidase-4 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Argentina Dipeptidyl Peptidase-4 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Middle East and Africa Dipeptidyl Peptidase-4 Inhibitors Sales Market Share by Country (2020-2031)
Figure 51. Middle East and Africa Dipeptidyl Peptidase-4 Inhibitors Revenue Market Share by Country (2020-2031)
Figure 52. Turkey Dipeptidyl Peptidase-4 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Saudi Arabia Dipeptidyl Peptidase-4 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. UAE Dipeptidyl Peptidase-4 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Global Sales Market Share of Dipeptidyl Peptidase-4 Inhibitors by Type (2020-2031)
Figure 56. Global Revenue Market Share of Dipeptidyl Peptidase-4 Inhibitors by Type (2020-2031)
Figure 57. Global Dipeptidyl Peptidase-4 Inhibitors Price (US$/Unit) by Type (2020-2031)
Figure 58. Global Sales Market Share of Dipeptidyl Peptidase-4 Inhibitors by Application (2020-2031)
Figure 59. Global Revenue Market Share of Dipeptidyl Peptidase-4 Inhibitors by Application (2020-2031)
Figure 60. Global Dipeptidyl Peptidase-4 Inhibitors Price (US$/Unit) by Application (2020-2031)
Figure 61. Dipeptidyl Peptidase-4 Inhibitors Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
